Tesla Best Performer in the S&P 500 and Nasdaq 100 So Far Today -- Data Talk
Dow Jones2026/08/31 14:37Tesla, Inc. (TSLA) is currently at $364.59, up $15.84 or 4.54%
--Would be highest close since July 22, 2026, when it closed at $374.01
--On pace for largest percent increase since Aug. 21, 2026, when it rose 5.14%
--Currently up three of the past five days
--Up 17.15% month-to-date
--Down 18.93% year-to-date
--Down 25.58% from its all-time closing high of $489.88 on Dec. 16, 2025
--Up 9.2% from 52 weeks ago (Aug. 29, 2025), when it closed at $333.87
--Down 25.58% from its 52-week closing high of $489.88 on Dec. 16, 2025
--Up 22.21% from its 52-week closing low of $298.32 on July 29, 2026
--Traded as high as $364.86; highest intraday level since Aug. 21, 2026, when it hit $366.50
--Up 4.62% at today's intraday high; largest intraday percent increase since Aug. 21, 2026, when it rose as much as 6.19%
--Best performer in the S&P 500 today
--Fourth most active stock in the S&P 500 today
--Best performer in the Nasdaq 100 today
--Fourth most active stock in the Nasdaq 100 today
All data as of 10:34:53 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 31, 2026 10:37 ET (14:37 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BNP Paribas gives Microsoft (MSFT.US) a "Buy" rating: Azure price increases will be gradually implemented after contract renewals, and a deal with SpaceX may be announced soon.
BNP Paribas has rated Microsoft as "Buy" with a target price of $549.
Iranian President will head to New York for UN meeting
"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%
Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.
700,000 new elderly patients join, Eli Lilly (LLY.US) dominates 70%: The first Medicare weight loss drug coverage report released
Dave Ricks, CEO of Eli Lilly (LLY.US), said in an interview on Monday that since Medicare began coverage for obesity drugs in July, 700,000 new elderly patients have started using GLP-1 medications.
Crypto prices
More
